16-72056174-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005143.5(HP):āc.19G>Cā(p.Val7Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,613,858 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005143.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HP | NM_005143.5 | c.19G>C | p.Val7Leu | missense_variant | 2/7 | ENST00000355906.10 | NP_005134.1 | |
HP | NM_001126102.3 | c.19G>C | p.Val7Leu | missense_variant | 2/5 | NP_001119574.1 | ||
HP | NM_001318138.2 | c.19G>C | p.Val7Leu | missense_variant | 2/5 | NP_001305067.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HP | ENST00000355906.10 | c.19G>C | p.Val7Leu | missense_variant | 2/7 | 1 | NM_005143.5 | ENSP00000348170.5 | ||
TXNL4B | ENST00000562153.5 | c.285-11817C>G | intron_variant | 4 | ENSP00000454635.2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152074Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000236 AC: 59AN: 249510Hom.: 0 AF XY: 0.000244 AC XY: 33AN XY: 135362
GnomAD4 exome AF: 0.000241 AC: 353AN: 1461784Hom.: 1 Cov.: 32 AF XY: 0.000239 AC XY: 174AN XY: 727190
GnomAD4 genome AF: 0.000210 AC: 32AN: 152074Hom.: 0 Cov.: 29 AF XY: 0.000229 AC XY: 17AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.19G>C (p.V7L) alteration is located in exon 2 (coding exon 2) of the HP gene. This alteration results from a G to C substitution at nucleotide position 19, causing the valine (V) at amino acid position 7 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at